华熙生物2025年营收42亿：同比降21% 净利2.9亿

雷递网03-02

雷递网雷建平 3月2日华熙生物（证券代码：688363）日前发布2025年业绩快报，业绩快报显示，华熙生物2025年营收42.17亿，较上年同期的53.71亿元降21.49%。华熙生物2025年运营利润为3.34亿元，较上年同期的2.16亿元增长54.63%；净利为2.91亿元，较上年同期的1.74亿元增长67%；扣非后净利为1.88亿元，较上年同期的1.07亿元增长75%。华熙生物称，报告期内...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2616333262?lang=zh_CN&edition=full","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260302/6390808169942304828177013.jpeg","is_english":false,"pubTime":"2026-03-02 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616333262","market":"hk","top_or_hot":-1,"title":"华熙生物2025年营收42亿：同比降21% 净利2.9亿","media":"雷递网","content":"<div>\n<p>雷递网 雷建平 3月2日华熙生物（证券代码：688363）日前发布2025年业绩快报，业绩快报显示，华熙生物2025年营收42.17亿，较上年同期的53.71亿元降21.49%。华熙生物2025年运营利润为3.34亿元，较上年同期的2.16亿元增长54.63%；净利为2.91亿元，较上年同期的1.74亿元增长67%；扣非后净利为1.88亿元，较上年同期的1.07亿元增长75%。华熙生物称，报告期内...</p>\n\n<a href=\"https://www.leinews.com/n32767/detail.html\">网页链接</a>\n\n</div>\n","source":"leinews_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华熙生物2025年营收42亿：同比降21% 净利2.9亿</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华熙生物2025年营收42亿：同比降21% 净利2.9亿\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-02 20:55 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.leinews.com/n32767/detail.html><strong>雷递网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>雷递网 雷建平 3月2日华熙生物（证券代码：688363）日前发布2025年业绩快报，业绩快报显示，华熙生物2025年营收42.17亿，较上年同期的53.71亿元降21.49%。华熙生物2025年运营利润为3.34亿元，较上年同期的2.16亿元增长54.63%；净利为2.91亿元，较上年同期的1.74亿元增长67%；扣非后净利为1.88亿元，较上年同期的1.07亿元增长75%。华熙生物称，报告期内...</p>\n\n<a href=\"https://www.leinews.com/n32767/detail.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688363","symbol_name":"华熙生物","start_time":0,"source_url":"https://www.leinews.com/n32767/detail.html","article_id":"2616333262","we_media_id":null,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260302/6390808169942304828177013.jpeg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616333262","pubTimestamp":1772456102,"columns":[],"sourceInfo":{"source_id":"leinews_highlight","name":"雷帝触网"},"weMediaInfo":null,"summary":"华熙生物（证券代码：688363）日前发布2025年业绩快报，业绩快报显示，华熙生物2025年营收42.17亿，较上年同期的53.71亿元降21.49%。","collect":0,"end_time":0,"defaultTopTitle":"leinews.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"688363":"华熙生物"},"translate_title":"Bloomage Biotech's revenue in 2025 is 4.2 billion: a year-on-year decrease of 21% and a net profit of 290 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688363":1.5},"content_text":"雷递网 雷建平 3月2日华熙生物（证券代码：688363）日前发布2025年业绩快报，业绩快报显示，华熙生物2025年营收42.17亿，较上年同期的53.71亿元降21.49%。华熙生物2025年运营利润为3.34亿元，较上年同期的2.16亿元增长54.63%；净利为2.91亿元，较上年同期的1.74亿元增长67%；扣非后净利为1.88亿元，较上年同期的1.07亿元增长75%。华熙生物称，报告期内，公司围绕皮肤科学创新转化业务和营养科学创新转化业务开展系统性结构优化，对相关业务对应的C端品牌体系、产品结构及渠道模式进行调整，压缩以销售额为单一指标的投放活动，减少部分投入产出效率较低的品牌及项目，将资源进一步集中于具备技术基础和产品积累的核心品牌及重点品类。上述结构性调整在短期内对收入规模产生一定影响，有助于优化业务结构。组织层面，公司整合职能重叠部门，优化层级设置，推动组织向扁平化、敏捷化升级，提升决策效率，有效降低运营成本，2025 年管理费用同比下降超过10%，成本与费用端的有效管控为利润增长提供了基础支撑。业务层面，公司坚持专业化聚焦发展方向，持续优化业务结构和资源配置。同时，公司通过加强供应链协同管理、推进库存结构优化，将更多资源投入到具备长期竞争优势的核心领域，2025年销售费用同比下降超过30%，在收入承压的背景下实现盈利能力持续改善。———————————————雷递由媒体人雷建平创办，若转载请写明来源。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616333262","isCrawlerRequest":true}